253 related articles for article (PubMed ID: 25380879)
21. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Mazanowska O; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Szyber P; Patrzałek D; Klinger M
Transplant Proc; 2013 May; 45(4):1462-5. PubMed ID: 23726597
[TBL] [Abstract][Full Text] [Related]
22. Preformed Angiotensin II Type-1 Receptor Antibodies Are Associated With Rejection After Kidney Transplantation: A Single-Center, Cohort Study.
Kim D; Gimferrer I; Warner P; Nelson K; Sibulesky L; Bakthavatsalam R; Leca N
Transplant Proc; 2018 Dec; 50(10):3467-3472. PubMed ID: 30577222
[TBL] [Abstract][Full Text] [Related]
23. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
Lim MA; Palmer M; Trofe-Clark J; Bloom RD; Jackson A; Philogene MC; Kamoun M
Hum Immunol; 2017 Apr; 78(4):350-356. PubMed ID: 28284829
[TBL] [Abstract][Full Text] [Related]
25. Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
Gerlach UA; Lachmann N; Ranucci G; Sawitzki B; Schoenemann C; Pratschke J; Dragun D; Pascher A
Transplantation; 2017 Jan; 101(1):141-149. PubMed ID: 27495766
[TBL] [Abstract][Full Text] [Related]
26. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
[TBL] [Abstract][Full Text] [Related]
27. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
Irure J; López-Hoyos M; Rodrigo E; Gómez-Román J; Ruiz JC; Arias M; San Segundo D
Transplant Proc; 2016 Nov; 48(9):2888-2890. PubMed ID: 27932099
[TBL] [Abstract][Full Text] [Related]
28. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
Pearl MH; Chen L; ElChaki R; Elashoff D; Gjertson DW; Rossetti M; Weng PL; Zhang Q; Reed EF; Chambers ET
Kidney Int Rep; 2020 Nov; 5(11):1925-1936. PubMed ID: 33163713
[TBL] [Abstract][Full Text] [Related]
29. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
[TBL] [Abstract][Full Text] [Related]
30. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
31. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
32. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
Pizzo H; Mirocha J; Choi J; Garrison J; Haas M; Zhang X; Kamil ES; Kim I; Jordan SC; Puliyanda DP
Pediatr Transplant; 2022 Dec; 26(8):e14400. PubMed ID: 36168673
[TBL] [Abstract][Full Text] [Related]
33. The role of endothelin II type A receptor (ETAR) in transplant injury.
Nowańska K; Wiśnicki K; Kuriata-Kordek M; Krajewska M; Banasik M
Transpl Immunol; 2022 Feb; 70():101505. PubMed ID: 34793957
[TBL] [Abstract][Full Text] [Related]
34. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
Taniguchi M; Rebellato LM; Cai J; Hopfield J; Briley KP; Haisch CE; Catrou PG; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Am J Transplant; 2013 Oct; 13(10):2577-89. PubMed ID: 23941128
[TBL] [Abstract][Full Text] [Related]
35. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
Crespo M; Llinàs-Mallol L; Redondo-Pachón D; Butler C; Gimeno J; Pérez-Sáez MJ; Burballa C; Buxeda A; Arias-Cabrales C; Folgueiras M; Sanz-Ureña S; Valenzuela NM; Reed EF; Pascual J
Front Immunol; 2021; 12():703457. PubMed ID: 34305943
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II Type 1 Receptor Expression in Renal Transplant Biopsies and Anti-AT1R Antibodies in Serum Indicates the Risk of Transplant Loss.
Sas-Strózik A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Gawlik K; Mazanowska O; Madziarska K; Hałoń A; Krajewska M; Banasik M
Transplant Proc; 2020 Oct; 52(8):2299-2304. PubMed ID: 32448653
[TBL] [Abstract][Full Text] [Related]
37. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral M; Foucher Y; Dufay A; Duong Van Huyen JP; Renaudin K; Moreau A; Philippe A; Hegner B; Dechend R; Heidecke H; Brouard S; Cesbron A; Castagnet S; Devys A; Soulillou JP; Dragun D
Am J Transplant; 2013 Oct; 13(10):2567-76. PubMed ID: 23919486
[TBL] [Abstract][Full Text] [Related]
38. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
Aziz F; Jung-Hynes B; Parajuli S; Redfield RR; Astor BC; Mandelbrot D; Hidalgo L; Djamali A
Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
[TBL] [Abstract][Full Text] [Related]
39. Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
In JW; Park H; Rho EY; Shin S; Park KU; Park MH; Song EY
Transplant Proc; 2014 Dec; 46(10):3371-4. PubMed ID: 25498054
[TBL] [Abstract][Full Text] [Related]
40. Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.
Hiemann NE; Meyer R; Wellnhofer E; Schoenemann C; Heidecke H; Lachmann N; Hetzer R; Dragun D
Transplantation; 2012 Nov; 94(9):919-24. PubMed ID: 23034559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
